Myocardial Norepinephrine Concentration in Man
- 26 September 1963
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 269 (13) , 653-658
- https://doi.org/10.1056/nejm196309262691302
Abstract
THE rauwolfia alkaloids have been widely used in clinical practice, but relatively little information concerning the mechanism of their circulatory action in man is available. Reserpine has been extensively studied in laboratory animals, and it has been demonstrated that after the parenteral administration of relatively large doses of this drug, postganglionic sympathetic nerves are no longer able to transmit impulses across the neuroeffector junctions.1 Also, in animals, a profound fall in the concentration of norepinephrine, epinephrine and serotonin throughout the body occurs after reserpine administration,2 3 4 and the sympathetic blockade produced by reserpine in laboratory animals has been attributed to the . . .Keywords
This publication has 22 references indexed in Scilit:
- Influence of Syrosingopine on the Cardiovascular Response to Acute Hypoxemia and ExerciseCirculation Research, 1961
- Psychotherapeutic DrugsAnnual Review of Medicine, 1961
- Estimation of Total Body Fat from RoentgenogramsScience, 1958
- The action of reserpine on the peripheral sympathetic systemThe Journal of Physiology, 1958
- Blood 5-Hydroxytryptamine (Serotonin) Levels after Reserpine and Electroshock Therapy.Experimental Biology and Medicine, 1957
- Serotonin Changes in Platelets and Brain Induced by Small Daily Doses of ReserpineNew England Journal of Medicine, 1957
- Reserpine and human platelet 5-hydroxytryptamineCellular and Molecular Life Sciences, 1956
- Release by reserpine of catechol amines from rabbits' heartsThe Science of Nature, 1956
- Serotonin Release as a Possible Mechanism of Reserpine ActionScience, 1955
- The measurement of volume changes in human limbsThe Journal of Physiology, 1953